Regenerative Medical Technology Group Inc.
RMTG
$0.0264
-$0.0126-32.31%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -149.30% | 84.85% | -2.29% | -17.41% | 74.20% |
| Total Depreciation and Amortization | -128.69% | -10.03% | 43.35% | 35.34% | 89.26% |
| Total Amortization of Deferred Charges | -99.42% | -91.36% | 34.81% | 33.79% | 74.87% |
| Total Other Non-Cash Items | 99.94% | -99.97% | 170.00% | 134.09% | -19,482.05% |
| Change in Net Operating Assets | 18.76% | 14.16% | 31.24% | 12.49% | 96.22% |
| Cash from Operations | 1,390.48% | 2,601.98% | 122.23% | 1,488.24% | 40.49% |
| Capital Expenditure | 82.39% | 41.36% | -1,021.28% | -976.36% | -314.60% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 82.39% | 41.36% | -1,021.28% | -976.36% | -314.60% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | 100.00% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | -- | -- | -4,515.38% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 153.70% | 370.07% | 109.16% | 667.44% | -392.69% |